June 2, 2026 | Eastern Time (US & Canada) | Online
Join leading parasitologists, clinicians, and researchers for a global virtual symposium dedicated to advancing research and collaboration in schistosomiasis.
Following the outstanding success of our 2025 edition, we are thrilled to invite you to join us online for the II Global Virtual Symposium on Schistosomiasis scheduled for June 2, 2026. Last year, we featured pioneering talks on schistosomiasis treatments, immunopathology, and control strategies from leading experts at Tufts, Penn State, Stanford, and beyond.
Your engagement last year sparked invaluable collaborations, and this year’s program builds on that momentum with fresh insights into drug development, genomics, and global health challenges.
Schistosomiasis remains a major global health challenge, causing significant morbidity and mortality worldwide. This symposium aims to foster collaboration, share cutting-edge research, and promote innovative solutions to improve public health outcomes.
This 1-day symposium will provide a valuable platform for basic, clinical, and translational research discussions. We look forward to welcoming you all on June 2, 2026 — Online.
Baylor College of Medicine, USA
mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni
Penn State University, USA
NLRP3 and AIM2 inflammasomes exacerbate the pathogenic Th17 cell response to eggs of Schistosoma mansoni
PAI Life Sciences, USA
Interim clinical trial results for the Schistosomiasis vaccine, SchistoShield
University of York, UK
Using a human receptor platform to identify extracellular host: parasite protein interactions during Schistosoma mansoni infection
Charité Universitätsmedizin Berlin, Germany
Update of WHO ultrasound protocol for Schistosomiasis: "The Basel protocol"
Universidade Federal do Espírito Santo, Brazil
Updated concerns about accuracy studies of Schistosomiasis diagnostic methods
QIMR Berghofer Medical Research Institute, Australia
Next-generation molecular technologies for enhanced Schistosomiasis control
TUM School of Medicine and Health, Germany
Lipid metabolism as a vulnerability in schistosomes
Brown University Health, USA
Praziquantel for the treatment of pregnant women with Schistosomiasis: results of an RCT
Brown University, USA
Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT addressing optimal dosing and impact on morbidity
University of Texas Health Science Center at Houston, USA
Exploring the host and parasite factors modulating schistosome development and immune evasion
Stanford University School of Medicine, CA, USA
To Be Updated
Hear groundbreaking studies from global experts.
Access recorded talks at your convenience.
Engage with professionals worldwide in live sessions.
Receive a certificate of participation.
Attend without travel or accommodation expenses.
Price: $39 per person
Number of Tickets: 1
Processing payment...